Efficacy and safety of valbenazine in the treatment of cervical dystonia: a pilot study
BackgroundVesicular monoamine transporter-2 inhibitors have provided on-label success in the treatment of tardive dyskinesia (TD) and Huntington’s disease chorea (HDC). A similar pathophysiological pathway for cervical dystonia suggests valbenazine (VBZ) could be beneficial in this condition.Objecti...
Saved in:
| Main Authors: | Salma Aziz, Erin Pellot, Laxman Bahroo, Abhishek Wajpe, Martin T. Taylor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Dystonia |
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/dyst.2025.13923/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
by: Richard L. Barbano, et al.
Published: (2025-03-01) -
Do female and male patients with cervical dystonia respond differently to long-term botulinum neurotoxin therapy?
by: Harald Hefter, et al.
Published: (2025-06-01) -
Family cervical dystonia, clinical case description
by: V. A. Suvorova, et al.
Published: (2021-06-01) -
Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
by: Carlos Henrique F. Camargo, et al.
Published: (2008-03-01) -
Distonias: aspectos terapêuticos Dystonias: therapeutic aspects
by: João Carlos Papaterra Limongi
Published: (1996-03-01)